| Ag | Antigen |
| CAR | Chimeric antigen receptor |
| CD19 CAR | Human anti-CD19-specific scFv CAR |
| CD19 CAR-expressing T cells | CAR-T cells, CD19 CAR-tTRII-T cells, and CD19 CAR-tTRII-I7R-T cells |
| CD19 CAR-tTRII-I7R-T cells | Co-expressing both CD19 CAR and tTRII-I7R-T cells |
| CSR | Chimeric switch receptor |
| Group CAR-19 | Mice receiving CD19 CAR-T cells |
| Group I7R | Mice receiving CD19 CAR-tTRII-I7R-T cells |
| Group tTRII | Mice receiving CD19 CAR-tTRII-T cells |
| IL | Interleukin |
| IU | International unit |
| NHL | Non-Hodgkin’s lymphoma |
| PBS | Phosphate-buffered saline |
| qRT-PCR | Quantitative reverse transcription-polymerase chain reaction |
| rh | Recombinant human |
| SMAD | Mothers against decapentaplegic homologs |
| TGF-β | Transforming growth factor-beta CD19 |
| TME | Tumor microenvironment |
| TR | TGF-β receptor |
| tTRII | Dominant negative TRII |
| tTRII-expressing T cells | CD19 CAR-tTRII-T cells and CD19 CAR-tTRII-I7R-T cells |
| tTRII-I7R | TGF-β/IL-7 CSR |